CAXTON CORP - MOLECULAR TEMPLATES INC ownership

Quarter-by-quarter ownership
CAXTON CORP ownership history of MOLECULAR TEMPLATES INC
ValueSharesWeighting
Q2 2023$985,436
+26.3%
2,052,9910.0%2.84%
+44.4%
Q1 2023$779,931
+15.8%
2,052,9910.0%1.97%
+14.5%
Q4 2022$673,381
-56.2%
2,052,9910.0%1.72%
-40.6%
Q3 2022$1,539,000
-17.8%
2,052,9910.0%2.89%
+15.1%
Q2 2022$1,872,000
-73.6%
2,052,9910.0%2.52%
-71.4%
Q1 2022$7,083,000
-15.5%
2,052,991
-4.0%
8.81%
+28.6%
Q4 2021$8,381,000
-41.6%
2,137,9910.0%6.85%
-41.1%
Q3 2021$14,346,000
-14.2%
2,137,9910.0%11.63%
+1.5%
Q2 2021$16,719,000
-37.6%
2,137,991
+0.7%
11.46%
-34.2%
Q1 2021$26,792,000
+34.4%
2,122,9910.0%17.40%
+40.1%
Q4 2020$19,935,000
-14.0%
2,122,9910.0%12.43%
-43.2%
Q3 2020$23,183,000
-20.2%
2,122,991
+0.7%
21.86%
-28.8%
Q2 2020$29,069,000
+3.8%
2,107,9910.0%30.68%
+0.2%
Q1 2020$28,015,000
-4.3%
2,107,991
+0.7%
30.62%
+8.5%
Q4 2019$29,270,000
+173.4%
2,092,991
+28.9%
28.23%
+133.9%
Q3 2019$10,704,000
-21.1%
1,624,2410.0%12.07%
-21.6%
Q2 2019$13,562,000
+43.7%
1,624,2410.0%15.40%
+75.9%
Q1 2019$9,437,000
+43.8%
1,624,2410.0%8.76%
+10.0%
Q4 2018$6,562,000
-23.9%
1,624,241
+1.6%
7.96%
-0.1%
Q3 2018$8,620,000
+56.4%
1,599,241
+51.8%
7.97%
+309.2%
Q2 2018$5,511,000
-33.7%
1,053,787
+1.4%
1.95%
-78.4%
Q1 2018$8,310,000
-18.2%
1,038,787
+2.5%
9.02%
-27.0%
Q4 2017$10,158,000
+43.8%
1,013,7870.0%12.35%
+71.7%
Q3 2017$7,066,0001,013,7877.19%
Other shareholders
MOLECULAR TEMPLATES INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 2,137,991$8,381,0006.85%
ACUTA CAPITAL PARTNERS, LLC 322,500$1,264,0000.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,021,317$4,004,0000.46%
BVF INC/IL 3,129,599$12,268,0000.44%
Bellevue Group AG 10,878,003$42,642,0000.44%
FRAZIER MANAGEMENT LLC 1,374,047$5,386,0000.42%
Endurant Capital Management LP 268,375$1,052,0000.25%
Abingworth LLP 200,000$780,0000.19%
Parkman Healthcare Partners LLC 147,728$579,0000.13%
GSA CAPITAL PARTNERS LLP 145,329$570,0000.07%
View complete list of MOLECULAR TEMPLATES INC shareholders